- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about YMAB
Recent news which mentions YMAB
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 31, 2023
From Benzinga
Why Chicken Soup for the Soul Entertainment Shares Are Trading Lower By 30%; Here Are 20 Stocks Moving Premarket
March 31, 2023
From Benzinga
Earnings Scheduled For March 30, 2023
March 30, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 24, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
From Benzinga
Y-mAbs Therapeutics Plans To Deprioritize Omburtamab For Pediatric Cancer, Cuts One Third Of Workforce
January 05, 2023
Tickers
YMAB
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
Looking Into Y-mAbs Therapeutics's Recent Short Interest
November 10, 2022
Tickers
YMAB
From Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 08, 2022
From Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 01, 2022
From Benzinga
ON Semiconductor, Global Payments And Other Big Losers From Monday
November 01, 2022
From Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
From Benzinga
Analysts Slash Y-mAbs Therapeutics Price Targets As Uncertainty Looms Over Neuroblastoma Hopeful
October 31, 2022
Tickers
YMAB
From Benzinga
S&P 500 Down 0.5%; Crude Oil Falls Sharply
October 31, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 31, 2022
From Benzinga
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
October 31, 2022
From Benzinga
Nasdaq Down Over 100 Points; Chicago PMI Drops Further
October 31, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
From Benzinga
US Stocks Start Week On Lower Note; Dow Dips Over 200 Points
October 31, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 31, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.